Cyanotech Corp Reports Director Departure, Officer Appointments
Ticker: CYAND · Form: 8-K · Filed: Aug 22, 2025 · CIK: 768408
| Field | Detail |
|---|---|
| Company | Cyanotech Corp (CYAND) |
| Form Type | 8-K |
| Filed Date | Aug 22, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $195,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-departure, officer-appointment, corporate-governance
TL;DR
Cyto director out, new execs in, shareholder votes on tap.
AI Summary
Cyanotech Corporation announced on August 21, 2025, the departure of Director Dr. Gerald R. Cysewski. The company also reported on the election of new directors and the appointment of certain officers, along with details on compensatory arrangements for these officers. Additionally, Cyanotech provided updates on matters submitted to a vote of its security holders and other significant events.
Why It Matters
Changes in board composition and officer appointments can signal shifts in company strategy or leadership, potentially impacting future performance and shareholder value.
Risk Assessment
Risk Level: medium — Director departures and executive changes, while common, can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Dr. Gerald R. Cysewski (person) — Departing Director
- Cyanotech Corporation (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
FAQ
Who is the departing director and when did their departure become effective?
Dr. Gerald R. Cysewski is the departing director, with the event reported as of August 21, 2025.
What other key events are reported in this 8-K filing?
The filing also reports on the election of directors, appointment of certain officers, compensatory arrangements for officers, matters submitted to a vote of security holders, and other events.
What is Cyanotech Corporation's state of incorporation and fiscal year end?
Cyanotech Corporation is incorporated in Nevada and its fiscal year ends on March 31.
What is the principal executive office address for Cyanotech Corporation?
The principal executive office is located at 73-4460 Queen Kaahumanu Highway, Suite #102, Kailua Kona, HI 96740.
What is the SIC code for Cyanotech Corporation?
The Standard Industrial Classification (SIC) code for Cyanotech Corporation is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Filing Stats: 1,033 words · 4 min read · ~3 pages · Grade level 11.3 · Accepted 2025-08-22 06:01:46
Key Financial Figures
- $195,000 — e will receive an annual base salary of $195,000 and will be eligible to receive a fisca
Filing Documents
- cyan20250821_8k.htm (8-K) — 40KB
- 0001437749-25-027547.txt ( ) — 161KB
- cyan-20250821.xsd (EX-101.SCH) — 3KB
- cyan-20250821_def.xml (EX-101.DEF) — 10KB
- cyan-20250821_lab.xml (EX-101.LAB) — 14KB
- cyan-20250821_pre.xml (EX-101.PRE) — 11KB
- cyan20250821_8k_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On August 21, 2025, the Company held its 2025 Annual Meeting of the Stockholders (the "Annual Meeting"). The Stockholders elected the four nominees to the Board of Directors (the "Board") named in the proxy statement and ratified the selection of BPM LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026. The final results for the votes regarding each item or proposal are set forth below. The proposals are described in detail in the Company's proxy statement filed with the Securities and Exchange Commission on July 10, 2025. 1. To elect four directors among the nominees named in the proxy statement. Name Votes For Votes Withheld Broker Non-Votes Matthew K. Custer 4,080,123 60,551 1,186,839 Michael A. Davis 4,017,112 123,562 1,186,839 David M. Mulder 4,018,081 122,593 1,186,839 David L. Vied 4,024,070 116,604 1,186,839 2. To ratify the selection of BPM LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026. Votes For Votes Against Abstentions Broker Non-Votes 5,167,992 155,517 4,004 - 3. To hold an advisory vote on the frequency of future advisory votes on the compensation of our Named Executive Officers. 3 YRS 2 YRS 1 YR Abstentions Non-Votes 3,953,481 20,675 136,864 29,654 1,186,839 Based on the results of the vote regarding the frequency of future advisory votes on the compensation of our Named Executive Officers, the Company will continue to provide an advisory vote on executive compensation every three years.
01 Other Events
Item 8.01 Other Events. On August 21, 2025, the Company held the Annual Organization Meeting (the "Organizational Meeting") of the Board. During the Organizational Meeting, it was resolved that Michael A. Davis, appointed Chairman of the Board, David M. Mulder and David L. Vied were all determined to be independent directors under Section 1.1(9) of the OTCQB Listing Rules. Also resolved was the appointment of committee members to the Board concurrent with their terms as directors, or until their earlier resignation or removal from such committee. Audit Committee Nominating and Corporate Governance Committee Compensation Committee David M. Mulder (Chair) Michael A. Davis (Chair) David L. Vied (Chair) David L. Vied David L. Vied Michael A. Davis
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYANOTECH CORPORATION Dated: August 22, 2025 /s/ Matthew K. Custer By: Matthew K. Custer President and Chief Executive Officer